MTBVAC from discovery to clinical trials in tuberculosis-endemic countries
D Marinova, J Gonzalo-Asensio, N Aguilo… - Expert review of …, 2017 - Taylor & Francis
Introduction: BCG remains the only vaccine against tuberculosis (TB) in use today and
despite its impressive global coverage, the nature of BCG protection against the pulmonary …
despite its impressive global coverage, the nature of BCG protection against the pulmonary …
Towards explaining the Swedish epidemic of celiac disease: an epidemiological approach
A Myléus - 2012 - diva-portal.org
Background: Celiac disease occurs worldwide in approximately 1% of the population,
whereof the majority of cases are undiagnosed. Sweden experienced an epidemic (1984 …
whereof the majority of cases are undiagnosed. Sweden experienced an epidemic (1984 …
Comments on the neonatal bacillus Calmette-Guerin vaccination: adding notes in proof of nonspecific effect
CGG Ponte, PRZ Antas, LM Peres… - American journal of …, 2013 - atsjournals.org
We read with interest the article by Ritz and colleagues (1) that found that early vaccination
using three related bacillus Calmette-Guérin (BCG) strains induces dissimilar patterns in …
using three related bacillus Calmette-Guérin (BCG) strains induces dissimilar patterns in …
Vaccines and disparities in male and female infant mortality in Guinea-Bissau: the problem of small numbers, high attrition rates and incomplete reporting
C Kruger - 2024 - adc.bmj.com
Peter Aaby and colleagues present again highly controversial data in the Archives, namely
that vaccines have non-specific effects on infant survival depending on the timing and …
that vaccines have non-specific effects on infant survival depending on the timing and …